Status:
TERMINATED
Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.
Lead Sponsor:
Imperial College London
Conditions:
COVID-19
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The outbreak of a novel coronavirus (SARS-CoV-2) and associated COVID-19 disease in late December 2019 has led to a global pandemic. At the time of writing, there have been 150 000 confirmed cases and...
Eligibility Criteria
Inclusion
- Confirmed COVID-19 infection
- Age =/\>40 or diabetes or known coronary disease or hypertension
- Requires hospital admission for further clinical management.
Exclusion
- Clear evidence of an acute coronary syndrome or myo-pericarditis that requires specific treatment that precludes randomization.
- Evidence of active bleeding
- Pregnancy.
- Age \<18 years
Key Trial Info
Start Date :
April 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT04333407
Start Date
April 3 2020
End Date
November 30 2021
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charing Cross Hospital
London, United Kingdom, W6 8RF